1 / 3

North American Oncolytic Virus Therapy Market Growth, Size, Share, Industry Report and Forecast to 2025

The North American oncolytic virus therapy market is estimated to grow at a CAGR of more than 16% during the forecast period. The market growth is attributed to the established research environment for various biotechnologies, the presence of major healthcare providers and growing healthcare investment in the US and Canada. Moreover, a growing number of cancer patients is augmenting the demand for oncolytic virus therapy. T-Vec (talimogene laherparepvec), is a recently approved oncolytic virus drug in the US and Europe. It is the second-generation oncolytic drug armed with GM-CSF to cure cancer.

larebomrglobal
Download Presentation

North American Oncolytic Virus Therapy Market Growth, Size, Share, Industry Report and Forecast to 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research North American Oncolytic Virus Therapy Market:Industry Growth, Size, Share and Forecast 2019-2025 Request a Free Report on Sample of https://www.omrglobal.com/request-sample/automotive-nfc-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780304040 North American Oncolytic Virus Therapy Market @

  2. The North American oncolytic virus therapy market is estimated to grow at a CAGR of more than 16% during the forecast period. The market growth is attributed to the established research environment for various biotechnologies, the presence of major healthcare providers and growing healthcare investment in the US and Canada. Moreover, a growing number of cancer patients is augmenting the demand for oncolytic virus therapy. T-Vec (talimogene laherparepvec), is a recently approved oncolytic virus drug in the US and Europe. It is the second-generation oncolytic drug armed with GM-CSF to cure cancer. A full Report of North American Oncolytic Virus Therapy Market is Available at: https://www.omrglobal.com/industry-reports/automotive-nfc-market Research is undergoing other oncolytic virus drugs to cure cancer patients suffering from brain tumors along with breast, lung, liver and bladder cancer. There are other oncolytic virus drugs being researched which include JX-594 (pexastimogenedevacirepvec) for hepatocellular carcinoma, GM-CSF-expressing adenovirus CG0070 for bladder cancer, and Reolysin (pelareorep), a wild-type variant of reovirus for head and neck cancer. Request a Free Report on Sample of North American https://www.omrglobal.com/request-sample/automotive-nfc-market The report covers the analysis of several players operating in the North American oncolytic virus therapy market. Some of the major players include Bristol-Myers Squibb Company, Abbvie Inc., Janssen Biotech Inc., Cold Genesys Inc., Cynvec LLC, and others. In December 2018, Bristol-Myers Squibb Company signed an agreement with PsiOxus Therapeutics, Ltd. to grant the company rights to NG-348, a pre-clinical stage, an armed oncolytic virus which addresses solid tumors. PsiOxus developed tumor-targeted delivery with oncolytic viruses’ platform, to target cancer and enable more patients to respond to treatment. The company has continued the study and development of immuno-oncology, which includes development in NG-348, in order to understand the potential of oncolytic viruses to boost checkpoint blockade in several types of cancer. Visit for Global Oncolytic Virus Therapy Market North American Oncolytic Virus Therapy Market – Segmentation By Product •HSV-Based Oncolytic Virus •Adenoviruses-Based Oncolytic Virus •Vaccinia Virus-Based Oncolytic Virus •Vesicular Stomatitis Virus-Based Oncolytic Virus •Newcastle Disease Virus- Based Oncolytic Virus •Others By Application Prostate Cancer Breast Cancer Ovarian Cancer Melanoma Others Oncolytic Virus Therapy Market @

  3. Regional Analysis US Canada Key players to contribute to the growth of the market AbbVie, Inc. Amgen, Inc. Bristol-Myers Squibb Company Cold Genesys Inc. Creative Biolabs Inc. Cynvec LLC DNAtrix Inc. Genelux Corp. Janssen Biotech Inc. Merck & Co., Inc. Oncolytic Biotech, Inc. Oncorus Inc. Sorrento Therapeutics Inc. Vyriad For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/north-american-oncolytic-virus-therapy-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related